captopril has been researched along with goralatide in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (45.45) | 18.2507 |
| 2000's | 5 (22.73) | 29.6817 |
| 2010's | 5 (22.73) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Adeline, MT; Gaudron, S; Potier, P; Thierry, J | 1 |
| Baggiolini, M | 1 |
| Erdös, EG | 1 |
| Azizi, M; Corvol, P; Ezan, E; Grognet, JM; Guyene, TT; Lenfant, M; Ménard, J; Michelet, S; Rousseau, A | 1 |
| Lenfant, M; Potier, P; Rousseau-Plasse, A | 1 |
| Chauvet, MT; Corvol, P; Michaud, A; Williams, TA | 1 |
| Chisi, JE; Riches, AC; Wdzieczak-Bakala, J | 1 |
| Azizi, M; Ezan, E; Gerineau, V; Ménard, J; Reny, JL; Wdzieczak-Bakala, J | 1 |
| Corvol, P; Ezan, E; Gonzales, MF; Junot, C; Menard, J; Michaud, A | 1 |
| Azizi, M; Ezan, E; Gonzales, MF; Junot, C; Menard, J; Nicolet, L | 1 |
| Briscoe, CV; Chisi, JE; Ezan, E; Genet, R; Riches, AC; Wdzieczak-Bakala, J | 1 |
| Azizi, M; Ezan, E; Guyene, T; Hallouin, MC; Junot, C; Ménard, J | 1 |
| Carretero, OA; Cavasin, MA; Rhaleb, NE; Yang, XP | 1 |
| Brigstock, DR; Carretero, OA; Cavasin, MA; Peng, H; Rasoul, S; Rhaleb, NE; Sanchez-Mendoza, A; Zhuo, J | 1 |
| Carretero, OA; Liao, TD; Peng, H; Peterson, EL; Rhaleb, NE | 1 |
| Araújo, RC; Barbosa, CM; Batista, EC; Bincoletto, C; Carmona, AK; Ferreira, AT; Martins, AH; Nascimento, FD; Oliveira, CR; Paredes-Gamero, EJ; Pesquero, JB; Reis, FC; Tersariol, IL | 1 |
| Chan, GC; Huang, XR; Lan, HY; Lin, M; Tang, SC; Wong, DW; Wu, HJ; Yiu, WH | 1 |
| Carretero, OA; Janic, B; Kumar, N; Monu, SR; Nakagawa, P; Niyitegeka, JM; Ongeri, EM; Peterson, EL; Rhaleb, NE; Romero, CA; Shaw, J; Valeriote, F; Worou, ME | 1 |
| Chan, GCW; Chan, KW; Huang, XR; Lai, KN; Lan, HY; Tang, SCW; Wu, HJ; Yiu, WH; Zou, A | 1 |
| Gao, X; Li, S; Wang, R; Wei, Z; Xu, D; Xu, H; Yang, F; Yi, X; Zhang, B; Zhang, G; Zhang, H; Zhang, L; Zhang, X; Zhang, Y; Zhu, Y | 1 |
| Gao, X; Ge, X; Jin, F; Li, S; Li, Y; Mao, N; Wei, Z; Xu, H; Yang, F; Yang, Y; Zhang, M; Zhang, Y | 1 |
| Barauna, VG; Bassaneze, V; Fernandes, T; Krieger, JE; Magalhães, FC; Marques, FLN; Mattos, KC; Menezes de Oliveira, E; Nava, R; Schettert, I | 1 |
3 trial(s) available for captopril and goralatide
| Article | Year |
|---|---|
Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline.
Topics: Administration, Oral; Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cross-Over Studies; Double-Blind Method; Growth Inhibitors; Hematopoiesis; Hematopoietic Stem Cells; Humans; Hydrolysis; Male; Oligopeptides; Peptidyl-Dipeptidase A; Placebos; Renin-Angiotensin System | 1996 |
Renal and metabolic clearance of N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) during angiotensin-converting enzyme inhibition in humans.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Humans; Kidney; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Oligopeptides; Peptidyl-Dipeptidase A | 1999 |
Functional consequences of angiotensin-converting enzyme gene polymorphism on N-acetyl-Ser-Asp-Lys-Pro degradation and angiotensin II production.
Topics: Adolescent; Adult; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cross-Over Studies; Female; Genotype; Homozygote; Humans; Male; Oligopeptides; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Single-Blind Method; Substrate Specificity | 2002 |
19 other study(ies) available for captopril and goralatide
| Article | Year |
|---|---|
NAcSDKP analogues resistant to angiotensin-converting enzyme.
Topics: Animals; Chromatography, High Pressure Liquid; Drug Stability; Growth Inhibitors; Hydrolysis; Kinetics; Oligopeptides; Oligosaccharides; Peptidyl-Dipeptidase A; Rabbits; Structure-Activity Relationship | 1997 |
Eotaxin: a VIC (very important chemokine) of allergic inflammation?
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Growth Inhibitors; Oligopeptides; Peptidyl-Dipeptidase A | 1996 |
News about ACE, or, the separate lives of "Siamese twin" domains.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Growth Inhibitors; Humans; Oligopeptides; Peptidyl-Dipeptidase A; Protein Conformation | 1996 |
Catabolism of the hemoregulatory peptide N-Acetyl-Ser-Asp-Lys-Pro: a new insight into the physiological role of the angiotensin-I-converting enzyme N-active site.
Topics: Binding Sites; Captopril; Growth Inhibitors; Hematopoiesis; Humans; Oligopeptides; Peptidyl-Dipeptidase A | 1996 |
Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Captopril; Chlorides; CHO Cells; Cricetinae; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Oligopeptides; Peptidyl-Dipeptidase A; Protein Structure, Tertiary; Substrate Specificity | 1997 |
Inhibitory action of the peptide AcSDKP on the proliferative state of hematopoietic stem cells in the presence of captopril but not lisinopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cell Cycle; Drug Interactions; Growth Inhibitors; Hematopoietic Stem Cells; Humans; Lisinopril; Mice; Oligopeptides; S Phase | 1997 |
In vivo assessment of captopril selectivity of angiotensin I-converting enzyme inhibition: differential inhibition of acetyl-ser-asp-lys-pro and angiotensin I hydrolysis.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Hydrolysis; Injections, Intravenous; Kinetics; Male; Oligopeptides; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Renin; Substrate Specificity; Time Factors | 1999 |
Effect of angiotensin-converting enzyme inhibition on plasma, urine, and tissue concentrations of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bone Marrow; Captopril; Dose-Response Relationship, Drug; Growth Inhibitors; Kidney; Lung; Male; Oligopeptides; Proteins; Rats; Rats, Wistar; Tissue Distribution | 1999 |
Captopril inhibits in vitro and in vivo the proliferation of primitive haematopoietic cells induced into cell cycle by cytotoxic drug administration or irradiation but has no effect on myeloid leukaemia cell proliferation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antimetabolites, Antineoplastic; Captopril; Cell Division; Cell Line; Cells, Cultured; Cytarabine; Hematopoietic Stem Cells; Interleukin-3; Leukemia, Myeloid; Macrophage Colony-Stimulating Factor; Mice; Mice, Inbred Strains; Oligopeptides; Peptidyl-Dipeptidase A; Recombinant Proteins; S Phase | 2000 |
Prolyl oligopeptidase is involved in release of the antifibrotic peptide Ac-SDKP.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dipeptides; Indoles; Kidney; Kidney Cortex; Male; Myocardium; Nitriles; Oligopeptides; Organ Specificity; Proline; Prolyl Oligopeptidases; Protease Inhibitors; Random Allocation; Rats; Rats, Sprague-Dawley; Serine Endopeptidases; Thiazoles; Thiazolidines; Thymosin | 2004 |
Antifibrotic effect of Ac-SDKP and angiotensin-converting enzyme inhibition in hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cell Division; Collagen; Connective Tissue Growth Factor; Drug Therapy, Combination; Fibrosis; Growth Inhibitors; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Kidney; Macrophages; Male; Mast Cells; Monocytes; Myocardium; Myocytes, Cardiac; Oligopeptides; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta | 2004 |
Role of N-acetyl-seryl-aspartyl-lysyl-proline in the antifibrotic and anti-inflammatory effects of the angiotensin-converting enzyme inhibitor captopril in hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antibodies, Monoclonal; Captopril; Disease Models, Animal; Enzyme Activation; Fibrosis; Heart; Hypertension; Inflammation; Kidney; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Oligopeptides; Rats | 2007 |
Myelopoiesis modulation by ACE hyperfunction in kinin B(1) receptor knockout mice: relationship with AcSDKP levels.
Topics: Animals; Bone Marrow Cells; Captopril; Granulocytes; Kallikrein-Kinin System; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Myelopoiesis; Oligopeptides; Peptidyl-Dipeptidase A; Receptor, Bradykinin B1; Renin-Angiotensin System | 2010 |
N-Acetyl-seryl-aspartyl-lysyl-proline Alleviates Renal Fibrosis Induced by Unilateral Ureteric Obstruction in BALB/C Mice.
Topics: Actins; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Chemokine CCL2; Collagen Type IV; Fibrosis; Immunohistochemistry; Inflammation; Kidney Diseases; Lymphocytes; Macrophages; Male; Mice; Mice, Inbred BALB C; Muscle, Smooth; Oligopeptides; Real-Time Polymerase Chain Reaction; Ureteral Obstruction | 2015 |
The anti-inflammatory peptide Ac-SDKP is released from thymosin-β4 by renal meprin-α and prolyl oligopeptidase.
Topics: Animals; Blood Pressure; Captopril; Hydroxamic Acids; Kidney; Male; Metalloendopeptidases; Mice, Inbred C57BL; Mice, Knockout; Oligopeptides; Prolyl Oligopeptidases; Random Allocation; Rats, Sprague-Dawley; Serine Endopeptidases; Thymosin | 2016 |
N-acetyl-seryl-aspartyl-lysyl-proline mediates the anti-fibrotic properties of captopril in unilateral ureteric obstructed BALB/C mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Disease Models, Animal; Extracellular Matrix Proteins; Fibrosis; Indoles; Kidney; Kidney Diseases; Male; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Oligopeptides; Peptidyl-Dipeptidase A; Prolyl Oligopeptidases; Serine Endopeptidases; Serine Proteinase Inhibitors; Signal Transduction; Thiazolidines; Transforming Growth Factor beta1; Ureteral Obstruction | 2018 |
Targeting the RAS axis alleviates silicotic fibrosis and Ang II-induced myofibroblast differentiation via inhibition of the hedgehog signaling pathway.
Topics: Adult; Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anthracosis; Captopril; Cell Differentiation; Cell Line; Collagen; Disease Models, Animal; Female; Hedgehog Proteins; Humans; Lung; Male; Middle Aged; Myofibroblasts; Oligopeptides; Peptide Fragments; Pulmonary Fibrosis; Rats, Wistar; Renin-Angiotensin System; Signal Transduction; Silicosis | 2019 |
N-Acetyl-Seryl-Asparyl-Lysyl-Proline regulates lung renin angiotensin system to inhibit epithelial-mesenchymal transition in silicotic mice.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cell Line; Epithelial-Mesenchymal Transition; Fibrosis; Losartan; Lung; Male; Mice, Inbred C57BL; Oligopeptides; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Silicosis | 2020 |
High-volume endurance exercise training stimulates hematopoiesis by increasing ACE NH2-terminal activity.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Endurance Training; Female; Hematopoiesis; Hematopoietic Stem Cells; Oligopeptides; Peptidyl-Dipeptidase A; Physical Conditioning, Animal; Physical Endurance; Protein Domains; Rats, Wistar; Time Factors | 2021 |